アスペルギルス症治療の世界市場レポート 2025年

アスペルギルス症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）6.5％で42億8,000万米ドルに成長します。予測期間の成長は、移植医療への需要、血液悪性腫瘍の流行、研究開発への投資の増加、公衆衛生への取り組みに起因しています。予測期間における主な動向には、抗真菌剤耐性、標的治療、治療薬モニタリング、医薬品開発などがあります。

真菌感染症の有病率の増加がアスペルギルス症治療市場の拡大を牽引すると予測されます。真菌感染症（真菌症）は、真菌によって引き起こされる疾患であり、ヒトと動物の両方に罹患する可能性があります。真菌感染症の一種であるアスペルギルス症は、呼吸器系、肺、脳、腎臓、その他の臓器など、身体のさまざまな部位に影響を及ぼす可能性があります。抗真菌薬ボリコナゾールなどのアスペルギルス症の治療は、感染を制御し、症状を緩和し、合併症を予防し、全身の健康を増進することを目的としています。例えば、2023年9月、英国健康安全保障局は、イングランドにおける血流イースト菌感染症の増加を報告し、症例数は2021年の人口10万人当たり3.8人から2022年には4.0人に増加しました。その結果、真菌感染症の罹患率の上昇がアスペルギルス症治療市場の成長を促進しています。

ヘルスケア支出の増加がアスペルギルス症治療市場の成長を促進すると予想されます。ヘルスケア支出には、医療サービス、家族計画、栄養プログラム、緊急健康支援に関連するすべての費用が含まれます。これらの支出の増加は、アスペルギルス症を管理するためのより効果的な治療や医療技術の進歩を支えています。例えば、2023年5月にOffice for National Statisticsが発表した英国のヘルスケア支出は約3,620億8,000万米ドル（2,920億英ポンド）に達し、名目で5.6％の増加を示しました。さらに、長期的な医療・社会的ケアへの支出は、2022年に実質ベースで2.8％増加しました。その結果、ヘルスケア支出の増加がアスペルギルス症治療市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界アスペルギルス症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のアスペルギルス症治療市場：成長率分析
• 世界のアスペルギルス症治療市場の実績：規模と成長, 2019-2024
• 世界のアスペルギルス症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界アスペルギルス症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアスペルギルス症治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アレルギー性アスペルギルス症
• 慢性アスペルギルス症
• 侵襲性アスペルギルス症
• その他のタイプ
• 世界のアスペルギルス症治療市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド
• 抗真菌薬
• その他の薬物クラス
• 世界のアスペルギルス症治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 注射可能
• その他の投与経路
• 世界のアスペルギルス症治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• その他の流通チャネル
• 世界のアスペルギルス症治療市場アレルギー性アスペルギルス症の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アレルギー性真菌性副鼻腔炎
• アレルギー性気管支肺アスペルギルス症（ABPA）
• 世界のアスペルギルス症治療市場慢性アスペルギルス症の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 慢性肺アスペルギルス症
• 慢性空洞性アスペルギルス症
• 世界のアスペルギルス症治療市場侵襲性アスペルギルス症の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 侵襲性肺アスペルギルス症
• 播種性侵襲性アスペルギルス症
• 世界のアスペルギルス症治療市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アスペルギローマ
• その他のまれなアスペルギルス症

第7章 地域別・国別分析

• 世界のアスペルギルス症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のアスペルギルス症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アスペルギルス症治療市場：競合情勢
• アスペルギルス症治療市場：企業プロファイル
  • Basilea Pharmaceutica Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Merck and Co. Inc.
• Sanofi S.A.
• Bristol Myers Squibb Company
• AstraZeneca plc
• GSK plc
• Takeda Pharmaceutical Company
• Eli Lilly and Company
• Gilead Sciences Inc.
• Boehringer Ingelheim International GmbH
• Teva Pharmaceutical Industries
• Astellas Pharma Inc.
• Regeneron Pharmaceuticals
• Mylan N.V.
• Sun Pharmaceutical Industries

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アスペルギルス症治療市場2029：新たな機会を提供する国
• アスペルギルス症治療市場2029：新たな機会を提供するセグメント
• アスペルギルス症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Aspergillosis treatment refers to addressing a fungal infection caused by the aspergillus species, with the specific approach depending on the severity and type of the disease. Aspergillosis can pose a serious and potentially life-threatening threat, particularly to individuals with compromised immune systems.

The primary categories of aspergillosis treatment encompass allergic aspergillosis, chronic aspergillosis, invasive aspergillosis, and other variants. Allergic aspergillosis, also recognized as allergic bronchopulmonary aspergillosis (ABPA), denotes a specific allergic response to the Aspergillus fungus, most frequently associated with Aspergillus fumigatus. Various classes of drugs are utilized, including corticosteroids, antifungal medications, and others. These treatments can be administered through oral, injectable, and alternative routes, and are distributed through a range of channels such as hospital pharmacies, retail pharmacies, and others.

The aspergillosis treatment market research report is one of a series of new reports from The Business Research Company that provides aspergillosis treatment market statistics, including aspergillosis treatment industry global market size, regional shares, competitors with an aspergillosis treatment market share, detailed aspergillosis treatment market segments, market trends and opportunities and any further data you may need to thrive in the aspergillosis treatment industry. This aspergillosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aspergillosis treatment market size has grown strongly in recent years. It will grow from $3.14 billion in 2024 to $3.33 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to diagnostic advancements, demand for antifungal medications, increased incidence, invasive procedures.

The aspergillosis treatment market size is expected to see strong growth in the next few years. It will grow to $4.28 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to demand for transplant medicine, prevalence of hematologic malignancies, increasing investments in research and development, public health initiatives. Major trends in the forecast period include antifungal resistance, targeted therapies, therapeutic drug monitoring, drug development.

The growing prevalence of fungal infections is anticipated to drive the expansion of the aspergillosis treatment market. Fungal infections, or mycoses, are diseases caused by fungi that can affect both humans and animals. Aspergillosis, a specific type of fungal infection, can impact various parts of the body, including the respiratory system, lungs, brain, kidneys, and other organs. Treatments for aspergillosis, such as the antifungal medication voriconazole, aim to control infection, relieve symptoms, prevent complications, and enhance overall health. For example, in September 2023, the UK Health Security Agency reported an increase in bloodstream yeast infections in England, with cases rising from 3.8 per 100,000 people in 2021 to 4.0 in 2022. Consequently, the rising incidence of fungal infections is fueling growth in the aspergillosis treatment market.

Increasing healthcare expenditures are expected to drive growth in the aspergillosis treatment market. Healthcare expenditures encompass all costs related to health services, family planning, nutrition programs, and emergency health assistance. An increase in these expenditures supports the advancement of more effective treatments and medical technologies for managing aspergillosis. For example, in May 2023, the Office for National Statistics reported that healthcare spending in the UK reached approximately $362.08 billion (£292 billion), marking a 5.6% nominal increase. Additionally, spending on long-term health and social care rose by 2.8% in real terms in 2022. As a result, rising healthcare spending is bolstering the aspergillosis treatment market's growth.

Prominent companies in the aspergillosis treatment sector are dedicated to introducing cutting-edge drugs and solutions to maintain their competitive edge. These breakthroughs in drug development broaden the spectrum of treatment options available for aspergillosis. An example of this progress is the introduction of posaconazole oral suspension, which offers more precise and efficient treatment choices for patients. Notably, in April 2023, Hikma Pharmaceuticals PLC, a UK-based pharmaceutical company, launched Posaconazole oral suspension in the US for treating aspergillosis. This medication is particularly relevant for patients with severely compromised immune systems, like hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD), who are at high risk of developing invasive aspergillus and candida infections. Furthermore, posaconazole oral suspension is recommended for oropharyngeal candidiasis (OPC), particularly when it proves refractory to itraconazole and fluconazole.

In May 2022, F2G Ltd., a pharmaceutical company based in England, entered into a partnership with Shionogi & Co., Ltd. to advance the development and commercialization of olorofim, an innovative antifungal treatment for invasive fungal infections, including invasive aspergillosis, across Europe and Asia. Shionogi & Co., Ltd., headquartered in Japan, specializes in developing treatments for invasive aspergillosis and other serious fungal infections.

Major companies operating in the aspergillosis treatment market are Basilea Pharmaceutica Ltd., Pfizer Inc., Johnson and Johnson, AbbVie Inc., Bayer AG, Novartis AG, Merck and Co. Inc., Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries, Astellas Pharma Inc., Regeneron Pharmaceuticals, Mylan N.V., Sun Pharmaceutical Industries, Jazz Pharmaceuticals, Dr. Reddy's Laboratories, Cipla Ltd., Bruker Corporation, Hikma Pharmaceuticals PLC.

North America was the largest region in the aspergillosis treatment market in 2024. The regions covered in aspergillosis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the aspergillosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aspergillosis treatment market consists of sales of immunotherapy drugs, echinocandin and azole antifungals. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aspergillosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aspergillosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aspergillosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aspergillosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Allergic Aspergillosis; Chronic Aspergillosis; Invasive Aspergillosis; Other Type
• 2) By Drug Class: Corticosteroids; Antifungal drugs; Other Drug Class
• 3) By Route of Administration: Oral; Injectable; Other Route Of Administration
• 4) By Distribution Channel: Hospital pharmacies; Retail pharmacies; Other Distribution Channel
• Subsegments:
• 1) By Allergic Aspergillosis: Allergic Fungal Sinusitis; Allergic Bronchopulmonary Aspergillosis (ABPA)
• 2) By Chronic Aspergillosis: Chronic Pulmonary Aspergillosis; Chronic Cavitary Aspergillosis
• 3) By Invasive Aspergillosis: Pulmonary Invasive Aspergillosis; Disseminated Invasive Aspergillosis
• 4) By Other Type: Aspergilloma; Other Rare Forms of Aspergillosis
• Companies Mentioned: Basilea Pharmaceutica Ltd.; Pfizer Inc.; Johnson and Johnson; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Aspergillosis Treatment Market Characteristics

3. Aspergillosis Treatment Market Trends And Strategies

4. Aspergillosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Aspergillosis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Aspergillosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Aspergillosis Treatment Market Growth Rate Analysis
• 5.4. Global Aspergillosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Aspergillosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Aspergillosis Treatment Total Addressable Market (TAM)

6. Aspergillosis Treatment Market Segmentation

• 6.1. Global Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allergic Aspergillosis
• Chronic Aspergillosis
• Invasive Aspergillosis
• Other Type
• 6.2. Global Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Antifungal drugs
• Other Drug Class
• 6.3. Global Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• Other Route Of Administration
• 6.4. Global Aspergillosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail pharmacies
• Other Distribution Channel
• 6.5. Global Aspergillosis Treatment Market, Sub-Segmentation Of Allergic Aspergillosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allergic Fungal Sinusitis
• Allergic Bronchopulmonary Aspergillosis (ABPA)
• 6.6. Global Aspergillosis Treatment Market, Sub-Segmentation Of Chronic Aspergillosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Pulmonary Aspergillosis
• Chronic Cavitary Aspergillosis
• 6.7. Global Aspergillosis Treatment Market, Sub-Segmentation Of Invasive Aspergillosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pulmonary Invasive Aspergillosis
• Disseminated Invasive Aspergillosis
• 6.8. Global Aspergillosis Treatment Market, Sub-Segmentation Of Other Type, By type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aspergilloma
• Other Rare Forms of Aspergillosis

7. Aspergillosis Treatment Market Regional And Country Analysis

• 7.1. Global Aspergillosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Aspergillosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Aspergillosis Treatment Market

• 8.1. Asia-Pacific Aspergillosis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Aspergillosis Treatment Market

• 9.1. China Aspergillosis Treatment Market Overview
• 9.2. China Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Aspergillosis Treatment Market

• 10.1. India Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Aspergillosis Treatment Market

• 11.1. Japan Aspergillosis Treatment Market Overview
• 11.2. Japan Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Aspergillosis Treatment Market

• 12.1. Australia Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Aspergillosis Treatment Market

• 13.1. Indonesia Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Aspergillosis Treatment Market

• 14.1. South Korea Aspergillosis Treatment Market Overview
• 14.2. South Korea Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Aspergillosis Treatment Market

• 15.1. Western Europe Aspergillosis Treatment Market Overview
• 15.2. Western Europe Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Aspergillosis Treatment Market

• 16.1. UK Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Aspergillosis Treatment Market

• 17.1. Germany Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Aspergillosis Treatment Market

• 18.1. France Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Aspergillosis Treatment Market

• 19.1. Italy Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Aspergillosis Treatment Market

• 20.1. Spain Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Aspergillosis Treatment Market

• 21.1. Eastern Europe Aspergillosis Treatment Market Overview
• 21.2. Eastern Europe Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Aspergillosis Treatment Market

• 22.1. Russia Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Aspergillosis Treatment Market

• 23.1. North America Aspergillosis Treatment Market Overview
• 23.2. North America Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Aspergillosis Treatment Market

• 24.1. USA Aspergillosis Treatment Market Overview
• 24.2. USA Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Aspergillosis Treatment Market

• 25.1. Canada Aspergillosis Treatment Market Overview
• 25.2. Canada Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Aspergillosis Treatment Market

• 26.1. South America Aspergillosis Treatment Market Overview
• 26.2. South America Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Aspergillosis Treatment Market

• 27.1. Brazil Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Aspergillosis Treatment Market

• 28.1. Middle East Aspergillosis Treatment Market Overview
• 28.2. Middle East Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Aspergillosis Treatment Market

• 29.1. Africa Aspergillosis Treatment Market Overview
• 29.2. Africa Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Aspergillosis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Aspergillosis Treatment Market Competitive Landscape
• 30.2. Aspergillosis Treatment Market Company Profiles
  • 30.2.1. Basilea Pharmaceutica Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Aspergillosis Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Merck and Co. Inc.
• 31.3. Sanofi S.A.
• 31.4. Bristol Myers Squibb Company
• 31.5. AstraZeneca plc
• 31.6. GSK plc
• 31.7. Takeda Pharmaceutical Company
• 31.8. Eli Lilly and Company
• 31.9. Gilead Sciences Inc.
• 31.10. Boehringer Ingelheim International GmbH
• 31.11. Teva Pharmaceutical Industries
• 31.12. Astellas Pharma Inc.
• 31.13. Regeneron Pharmaceuticals
• 31.14. Mylan N.V.
• 31.15. Sun Pharmaceutical Industries

32. Global Aspergillosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aspergillosis Treatment Market

34. Recent Developments In The Aspergillosis Treatment Market

35. Aspergillosis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Aspergillosis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Aspergillosis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Aspergillosis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer